Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eusebio Chiefari

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Diabetes Technology & Therapeutics|April 7, 2015
Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin TherapyEusebio Chiefari, Carmelo Capula, Ada Vero, et al.
International Journal of Environmental Research and Public Health|January 2, 2020
Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 DiabetesMaria Mirabelli, Eusebio Chiefari, Patrizia Caroleo, et al.
Cancer Research|May 19, 2006
Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancerFrancesco Paonessa, Daniela Foti, Vanessa Costa, et al.
Nature Medicine|June 1, 2005
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and miceDaniela Foti, Eusebio Chiefari, Monica Fedele, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804Francesca Lombardo, Eric Baudin, Eusebio Chiefari, et al.
Diagnostics (Basel, Switzerland)|July 29, 2023
From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA SignaturesMarta Greco, Maria Mirabelli, Alessandro Salatino, et al.
Frontiers in Endocrinology|December 12, 2022
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1Alessandro Salatino, Maria Mirabelli, Eusebio Chiefari, et al.
Diagnostics (Basel, Switzerland)|January 22, 2024
Coexistence of Hashimoto's Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment ResponseAlessandra Donnici, Maria Mirabelli, Stefania Giuliano, et al.
Journal of Clinical Medicine|April 12, 2025
Circulating Thrombospondin-1 and Endothelin-1 Levels Tend to Decline with Increasing Obesity Severity in Women: Evidence from a Pilot, Cross-Sectional StudyMarta Greco, Maria Mirabelli, Luciana Sicilia, et al.
Proteomics|February 22, 2018
Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in ObesityAnna Elisa Laria, Sebastiano Messineo, Biagio Arcidiacono, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Diabetes Technology & Therapeutics|April 7, 2015
Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin TherapyEusebio Chiefari, Carmelo Capula, Ada Vero, et al.
International Journal of Environmental Research and Public Health|January 2, 2020
Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 DiabetesMaria Mirabelli, Eusebio Chiefari, Patrizia Caroleo, et al.
Cancer Research|May 19, 2006
Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancerFrancesco Paonessa, Daniela Foti, Vanessa Costa, et al.
Nature Medicine|June 1, 2005
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and miceDaniela Foti, Eusebio Chiefari, Monica Fedele, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804Francesca Lombardo, Eric Baudin, Eusebio Chiefari, et al.
Diagnostics (Basel, Switzerland)|July 29, 2023
From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA SignaturesMarta Greco, Maria Mirabelli, Alessandro Salatino, et al.
Frontiers in Endocrinology|December 12, 2022
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1Alessandro Salatino, Maria Mirabelli, Eusebio Chiefari, et al.
Diagnostics (Basel, Switzerland)|January 22, 2024
Coexistence of Hashimoto's Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment ResponseAlessandra Donnici, Maria Mirabelli, Stefania Giuliano, et al.
Journal of Clinical Medicine|April 12, 2025
Circulating Thrombospondin-1 and Endothelin-1 Levels Tend to Decline with Increasing Obesity Severity in Women: Evidence from a Pilot, Cross-Sectional StudyMarta Greco, Maria Mirabelli, Luciana Sicilia, et al.
Proteomics|February 22, 2018
Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in ObesityAnna Elisa Laria, Sebastiano Messineo, Biagio Arcidiacono, et al.
Pageof 8